Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 5, Pages 704-718
Publisher
Wiley
Online
2015-12-22
DOI
10.1016/j.molonc.2015.12.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological Regulation of Platelet Factors That Influence Tumor Angiogenesis
- (2014) MengJie Yan et al. SEMINARS IN ONCOLOGY
- Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
- (2013) Robert S. Kerbel et al. BREAST
- Angiopoietins and Non–Vascular Endothelial Growth Factor Antiangiogenic Targets in Advanced Renal Cell Carcinoma
- (2013) Stephen L. Richey et al. CANCER JOURNAL
- Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
- (2013) Gabriel Limaverde-Sousa et al. CANCER TREATMENT REVIEWS
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications
- (2013) Rajan Jain NMR IN BIOMEDICINE
- Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
- (2013) P. R. Lawler et al. Cold Spring Harbor Perspectives in Medicine
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- Quantification of Antiangiogenic and Antivascular Drug Activity by Kinetic Analysis of DCE-MRI Data
- (2012) G Z Ferl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Novel targets for VEGF-independent anti-angiogenic drugs
- (2012) Marco Petrillo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Strategies for Improving the Clinical Benefit of Antiangiogenic Drug Based Therapies for Breast Cancer
- (2012) Robert S. Kerbel JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis
- (2012) Zhi-Yuan Chen et al. Journal of Translational Medicine
- Reappraising antiangiogenic therapy for breast cancer
- (2011) Robert S. Kerbel BREAST
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- The 2-Nitroimidazole EF5 Is a Biomarker for Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under Hypoxia
- (2011) J. Wang et al. CLINICAL CANCER RESEARCH
- Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma
- (2011) Hung Huynh et al. JOURNAL OF HEPATOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signaling Pathways Governing Tumor Angiogenesis
- (2011) Toshiharu Sakurai et al. ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now